Bone Formation and Osseointegration Stimulated by rhBMP-2 Following Subantral Augmentation Procedures in Nonhuman Primates

Oliver Hanisch, Dimitris N. Tatakis, Michael D. Rohrer, Peter S. Wöhrle, John M. Wozney, Ulf M E Wikesjö

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

The purpose of this study was to evaluate bone formation and osseointegration using titanium dental implants in the subantral space following surgical implantation of recombinant human bone morphogenetic protein-2 (rhBMP-2). In each of four cynomolgus monkeys, one subantral site was treated with rhBMP-2 (0.19 mg per implant) in an absorbable collagen sponge (ACS). The contralateral site was treated with vehicle in ACS (control). Three months later, two screw-type titanium dental implants were placed into each augmented sinus, and one additional implant was placed immediately anterior to the sinus. Thus, each animal had three experimental sites: rhBMP-2, control, and nonsinus. Animals were sacrificed after an additional 3 months, and block sections were harvested and prepared for histometric analysis. Analysis of variance and t tests were used to evaluate differences between experimental conditions. Mean (± SD) vertical bone gain was significantly greater in rhBMP-2 than in control sites (6.0 ± 0.3 versus 2.6 ± 0.3 mm; P < .002). Bone density in rhBMP-2 sites averaged 14.4 ± 2.9% versus 13.9 ± 4.6% and 14.1 ± 3.6% for control and nonsinus sites, respectively, without significant differences between experimental conditions. Bone-implant contact in rhBMP-2 sites (41.4 ± 7.7%) was not significantly different from that in control (38.9 ± 12.4%) and nonsinus sites (46.8 ± 10.6%). The present study provides evidence for considerable vertical bone gain in the subantral space following surgical implantation of rhBMP-2, thus allowing placement of dental implants. The newly formed bone appears to be of similar quality and to be as suitable for osseointegration as the residual bone in this nonhuman primate model. Thus, surgical implantation of rhBMP-2 appears to have clinical utility and may provide a realistic alternative to autogenous bone grafts for subantral augmentation procedures.

Original languageEnglish (US)
Pages (from-to)785-792
Number of pages8
JournalInternational Journal of Oral and Maxillofacial Implants
Volume12
Issue number6
StatePublished - Dec 1 1997

Fingerprint

Osseointegration
Osteogenesis
Primates
Bone and Bones
Dental Implants
Porifera
Titanium
Collagen
Absorbable Implants
Macaca fascicularis
recombinant human bone morphogenetic protein-2
Bone Density
Analysis of Variance
Transplants

Keywords

  • Bone density/formation
  • Bone morphogenetic protein
  • Dental implants
  • Nonhuman primates
  • Osseointegration
  • Subantral augmentation

ASJC Scopus subject areas

  • Oral Surgery

Cite this

Hanisch, O., Tatakis, D. N., Rohrer, M. D., Wöhrle, P. S., Wozney, J. M., & Wikesjö, U. M. E. (1997). Bone Formation and Osseointegration Stimulated by rhBMP-2 Following Subantral Augmentation Procedures in Nonhuman Primates. International Journal of Oral and Maxillofacial Implants, 12(6), 785-792.

Bone Formation and Osseointegration Stimulated by rhBMP-2 Following Subantral Augmentation Procedures in Nonhuman Primates. / Hanisch, Oliver; Tatakis, Dimitris N.; Rohrer, Michael D.; Wöhrle, Peter S.; Wozney, John M.; Wikesjö, Ulf M E.

In: International Journal of Oral and Maxillofacial Implants, Vol. 12, No. 6, 01.12.1997, p. 785-792.

Research output: Contribution to journalArticle

Hanisch, Oliver ; Tatakis, Dimitris N. ; Rohrer, Michael D. ; Wöhrle, Peter S. ; Wozney, John M. ; Wikesjö, Ulf M E. / Bone Formation and Osseointegration Stimulated by rhBMP-2 Following Subantral Augmentation Procedures in Nonhuman Primates. In: International Journal of Oral and Maxillofacial Implants. 1997 ; Vol. 12, No. 6. pp. 785-792.
@article{277b770c737f491c99e54b6b25b015da,
title = "Bone Formation and Osseointegration Stimulated by rhBMP-2 Following Subantral Augmentation Procedures in Nonhuman Primates",
abstract = "The purpose of this study was to evaluate bone formation and osseointegration using titanium dental implants in the subantral space following surgical implantation of recombinant human bone morphogenetic protein-2 (rhBMP-2). In each of four cynomolgus monkeys, one subantral site was treated with rhBMP-2 (0.19 mg per implant) in an absorbable collagen sponge (ACS). The contralateral site was treated with vehicle in ACS (control). Three months later, two screw-type titanium dental implants were placed into each augmented sinus, and one additional implant was placed immediately anterior to the sinus. Thus, each animal had three experimental sites: rhBMP-2, control, and nonsinus. Animals were sacrificed after an additional 3 months, and block sections were harvested and prepared for histometric analysis. Analysis of variance and t tests were used to evaluate differences between experimental conditions. Mean (± SD) vertical bone gain was significantly greater in rhBMP-2 than in control sites (6.0 ± 0.3 versus 2.6 ± 0.3 mm; P < .002). Bone density in rhBMP-2 sites averaged 14.4 ± 2.9{\%} versus 13.9 ± 4.6{\%} and 14.1 ± 3.6{\%} for control and nonsinus sites, respectively, without significant differences between experimental conditions. Bone-implant contact in rhBMP-2 sites (41.4 ± 7.7{\%}) was not significantly different from that in control (38.9 ± 12.4{\%}) and nonsinus sites (46.8 ± 10.6{\%}). The present study provides evidence for considerable vertical bone gain in the subantral space following surgical implantation of rhBMP-2, thus allowing placement of dental implants. The newly formed bone appears to be of similar quality and to be as suitable for osseointegration as the residual bone in this nonhuman primate model. Thus, surgical implantation of rhBMP-2 appears to have clinical utility and may provide a realistic alternative to autogenous bone grafts for subantral augmentation procedures.",
keywords = "Bone density/formation, Bone morphogenetic protein, Dental implants, Nonhuman primates, Osseointegration, Subantral augmentation",
author = "Oliver Hanisch and Tatakis, {Dimitris N.} and Rohrer, {Michael D.} and W{\"o}hrle, {Peter S.} and Wozney, {John M.} and Wikesj{\"o}, {Ulf M E}",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "12",
pages = "785--792",
journal = "The International journal of oral & maxillofacial implants",
issn = "0882-2786",
publisher = "Quintessence Publishing Company",
number = "6",

}

TY - JOUR

T1 - Bone Formation and Osseointegration Stimulated by rhBMP-2 Following Subantral Augmentation Procedures in Nonhuman Primates

AU - Hanisch, Oliver

AU - Tatakis, Dimitris N.

AU - Rohrer, Michael D.

AU - Wöhrle, Peter S.

AU - Wozney, John M.

AU - Wikesjö, Ulf M E

PY - 1997/12/1

Y1 - 1997/12/1

N2 - The purpose of this study was to evaluate bone formation and osseointegration using titanium dental implants in the subantral space following surgical implantation of recombinant human bone morphogenetic protein-2 (rhBMP-2). In each of four cynomolgus monkeys, one subantral site was treated with rhBMP-2 (0.19 mg per implant) in an absorbable collagen sponge (ACS). The contralateral site was treated with vehicle in ACS (control). Three months later, two screw-type titanium dental implants were placed into each augmented sinus, and one additional implant was placed immediately anterior to the sinus. Thus, each animal had three experimental sites: rhBMP-2, control, and nonsinus. Animals were sacrificed after an additional 3 months, and block sections were harvested and prepared for histometric analysis. Analysis of variance and t tests were used to evaluate differences between experimental conditions. Mean (± SD) vertical bone gain was significantly greater in rhBMP-2 than in control sites (6.0 ± 0.3 versus 2.6 ± 0.3 mm; P < .002). Bone density in rhBMP-2 sites averaged 14.4 ± 2.9% versus 13.9 ± 4.6% and 14.1 ± 3.6% for control and nonsinus sites, respectively, without significant differences between experimental conditions. Bone-implant contact in rhBMP-2 sites (41.4 ± 7.7%) was not significantly different from that in control (38.9 ± 12.4%) and nonsinus sites (46.8 ± 10.6%). The present study provides evidence for considerable vertical bone gain in the subantral space following surgical implantation of rhBMP-2, thus allowing placement of dental implants. The newly formed bone appears to be of similar quality and to be as suitable for osseointegration as the residual bone in this nonhuman primate model. Thus, surgical implantation of rhBMP-2 appears to have clinical utility and may provide a realistic alternative to autogenous bone grafts for subantral augmentation procedures.

AB - The purpose of this study was to evaluate bone formation and osseointegration using titanium dental implants in the subantral space following surgical implantation of recombinant human bone morphogenetic protein-2 (rhBMP-2). In each of four cynomolgus monkeys, one subantral site was treated with rhBMP-2 (0.19 mg per implant) in an absorbable collagen sponge (ACS). The contralateral site was treated with vehicle in ACS (control). Three months later, two screw-type titanium dental implants were placed into each augmented sinus, and one additional implant was placed immediately anterior to the sinus. Thus, each animal had three experimental sites: rhBMP-2, control, and nonsinus. Animals were sacrificed after an additional 3 months, and block sections were harvested and prepared for histometric analysis. Analysis of variance and t tests were used to evaluate differences between experimental conditions. Mean (± SD) vertical bone gain was significantly greater in rhBMP-2 than in control sites (6.0 ± 0.3 versus 2.6 ± 0.3 mm; P < .002). Bone density in rhBMP-2 sites averaged 14.4 ± 2.9% versus 13.9 ± 4.6% and 14.1 ± 3.6% for control and nonsinus sites, respectively, without significant differences between experimental conditions. Bone-implant contact in rhBMP-2 sites (41.4 ± 7.7%) was not significantly different from that in control (38.9 ± 12.4%) and nonsinus sites (46.8 ± 10.6%). The present study provides evidence for considerable vertical bone gain in the subantral space following surgical implantation of rhBMP-2, thus allowing placement of dental implants. The newly formed bone appears to be of similar quality and to be as suitable for osseointegration as the residual bone in this nonhuman primate model. Thus, surgical implantation of rhBMP-2 appears to have clinical utility and may provide a realistic alternative to autogenous bone grafts for subantral augmentation procedures.

KW - Bone density/formation

KW - Bone morphogenetic protein

KW - Dental implants

KW - Nonhuman primates

KW - Osseointegration

KW - Subantral augmentation

UR - http://www.scopus.com/inward/record.url?scp=0031261492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031261492&partnerID=8YFLogxK

M3 - Article

C2 - 9425759

AN - SCOPUS:0031261492

VL - 12

SP - 785

EP - 792

JO - The International journal of oral & maxillofacial implants

JF - The International journal of oral & maxillofacial implants

SN - 0882-2786

IS - 6

ER -